POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN
The present invention relates to aqueous solutions useful as pharmaceutical compositions of posaconazole for intravenous administration. These compositions include a solubilizing agent, such as a modified beta-cyclodextrin in an acidified solution, which can also include a chelating agent such as di...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
18.04.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to aqueous solutions useful as pharmaceutical compositions of posaconazole for intravenous administration. These compositions include a solubilizing agent, such as a modified beta-cyclodextrin in an acidified solution, which can also include a chelating agent such as disodium edetate (EDTA). In clinical trials, a 200 mg posaconazole dose of the selected composition was found to achieve acceptable pharmacokinetic properties. |
---|---|
Bibliography: | Application Number: US201113704145 |